Rachel Laing

Rachel Laing is the Managing Director and Partner at Bionest Partners, a global consulting firm focused on the pharmaceutical, biotech, medical device, and diagnostics industries.12 She brings over 15 years of scientific and consulting expertise to her role.1

Rachel has been with Bionest since 2010, working in various locations including New York, Basel, Switzerland, and currently in Cambridge, UK.1 Her expertise lies in supporting pharma, biotech, and diagnostic companies on strategic assignments, particularly in new product planning and go-to-market strategies.12

Career Progression

• Managing Director & Partner: September 2022 - Present (Cambridgeshire, England)1
• Managing Director: January 2018 - August 2022 (Basel, Switzerland)1
• Partner: July 2017 - August 2022 (Basel Area, Switzerland)1
• Manager: September 2015 - July 2017 (Basel, Switzerland)1
• Manager: October 2014 - September 2015 (Greater New York City Area)1
• Senior Consultant: January 2013 - October 2014 (Greater New York City Area)1
• Consultant: August 2010 - January 2013 (Greater New York City Area)1

Expertise and Leadership

Rachel leads the Oncology and Precision Medicine practices at Bionest and is recognized as a thought leader in these areas.12 She has a specific passion for oncology and diagnostics, stemming from her scientific background.1

Education

• Ph.D. in Molecular and Medical Pharmacology: UCLA (2006 - 2010)1
• M.S. in Pharmacology: University of Oxford (2005 - 2006)1
• B.S. in Molecular, Cell and Developmental Biology: UCLA (2001 - 2005)1

In February 2023, Accenture acquired Bionest, with Rachel Laing joining Accenture Strategy in the Life Sciences practice as part of this acquisition.3